History

Adopted as Kawasaki Deep Tech Accelerator in August 2019

September 2019     NEDO NEP adopted

November 2019   STAND Therapeutics Co. Ltd., was established. Hiroyuki Kabayama appointed as Representative Director

November 2019    Adopted by Kanagawa Prefecture Regenerative and Cellular Medicine Industrialization Promotion Project in 2019

July 2020 Adopted by the Patent Office Intellectual Property Accelerator IPAS2020

August 2020 Adopted as Kanagawa Prefecture Regenerative and Cellular Medicine Industrialization Promotion Project for FY2020

August 2020 Tokyo drug discovery venture accelerator Blockbuster TOKYO adopted

September 2020 Mitsubishi UFJ Technology Development Foundation R&D Grant Adopted

September 2020 Winner of the Boehringer Ingelheim Innovation Prize 2020

March 2021 Hamagin Industrial Culture Promotion Foundation Frontiers research and development subsidy

April 2021 National Cancer Center Hospital East Venture Incubation Program (NCC-VIP) adopted

August 2021 Adopted as Kanagawa Prefecture Regenerative and Cellular Medicine Industrialization Promotion Project for 2021

April 2022 Fundraising through the issuance of the first J-KISS type stock acquisition rights, with RaQualia Pharma Inc. as the underwriter.

July 2022 Concluded a joint development agreement with RaQualia Pharma Inc. for the treatment of intractable and rare diseases that target ion channels